General Information of Drug (ID: DMCRQ29)

Drug Name
S-benzo[d]oxazol-2-yl O-butyl carbonothioate
Synonyms
MLS000105935; butyl 1,3-benzoxazol-2-ylsulfanylformate; SMR000102909; AC1M2XFY; CHEMBL1253382; cid_2202888; BDBM33627; MolPort-002-144-521; HMS2405D05; HMS1580J19; ZINC2848864; MCULE-9572612001; butyl 1,3-benzoxazol-2-ylsulfanylmethanoate; AB00080574-01; (1,3-benzoxazol-2-ylthio)formic acid butyl ester
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 251.3
Logarithm of the Partition Coefficient (xlogp) 4
Rotatable Bond Count (rotbonds) 6
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C12H13NO3S
IUPAC Name
butyl 1,3-benzoxazol-2-ylsulfanylformate
Canonical SMILES
CCCCOC(=O)SC1=NC2=CC=CC=C2O1
InChI
InChI=1S/C12H13NO3S/c1-2-3-8-15-12(14)17-11-13-9-6-4-5-7-10(9)16-11/h4-7H,2-3,8H2,1H3
InChIKey
MJTKQBGLMBYWSU-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
2202888
TTD ID
D0O4BU

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MIF messenger RNA (MIF mRNA) TT6804T MIF_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem. 2010 Jul 15;18(14):5425-40.